Weight Loss Study With Two New Injectable Medications
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have obesity or are overweight (body weight above a certain threshold)
- You do not have type 1 or type 2 diabetes
- You do not have a history of pancreatitis (inflammation of the pancreas)
- Your resting heart rate is between 60 and 100 beats per minute
- You do not have bradycardia or irregular heartbeats related to slow heart rate
- Any regular medications you take must have been at the same dose for at least 3 months before screening
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two new medicines, alone or together, to see if they help with weight loss and blood sugar control in adults who have type 2 diabetes and are overweight or have obesity.
This study tests two new experimental medications designed to help adults lose weight and improve weight-related health conditions like high blood pressure and sleep apnea. Participants will take one of these medications to see if it's safe and effective.
This study tests an investigational drug called macupatide to see if it can help people with overweight or obesity lose weight. It is for Japanese adults who do not have type 2 diabetes and have had a stable weight for the past 3 months.
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.